Skip to content

Expertise Hub Pharma & Biotech

  • Why cleanability is determined at the design stage

    Learn more
  • Technologies, requirements, and applications at a glance

    Learn more
  • What Annex 1 means for the design of your isolator

    Learn more

Every injectable drug starts with a process you can rely on. Here you’ll find the knowledge to design aseptic processes that are safe, stable, and built for the future.

Grade A isn’t a component you can simply install. It is the result of knowledge: about airflow and filtration, decontamination and material transfer, Annex 1, sterility assurance, and the interplay of people, equipment, and process. Our expertise section brings this knowledge together along your product’s journey, from clinical development through commercial manufacturing to quality control. Experts from across the SKAN Group share what they have learned through many years of project experience and close dialogue with regulatory authorities—so you can identify risks early, make decisions with confidence, reach approval faster, and maintain Grade A throughout ongoing operations.

Typical pharmaceutical production process

The most crucial steps within the isolator

  • 1

    Weighing and dispensing

    Active ingredients and excipients are weighed and dispensed. For potent substances – and for early-phase compounds whose toxicity is not yet fully known – containment protects operators and prevents cross-contamination.

    → Read more about powder handling

  • 2

    Formulation

    Ingredients are dissolved or mixed into the bulk. Solutions that can be sterile-filtered are formulated in closed vessels; products that cannot be filtered must be formulated aseptically in an isolator.

    → Read more about formulation isolators

  • 3

    Component and material supply

    Containers, closures, tools and consumables must enter Grade A without breaching the barrier or leaving H₂O₂ residuals – occasionally for a clinical batch, continuously on a commercial line.

    → Read more about material transfer

  • 4

    Liquid transfer to the filling line

    The bulk solution must reach the filling needles through a closed, sterile path. Sterile filtration, aseptic connections and single-use assemblies reduce cleaning effort and contamination risk.

    → Read more about liquid transfer

  • 5

    Aseptic filling

    The open product is most exposed during filling. Requirements change with each phase: flexibility and minimal product loss for clinical and small batches, speed and availability for commercial high-volume lines.

    → Read more about small & medium batch filling
    → Read more about large-scale filling

  • 6

    Quality control and release

    Environmental monitoring shows whether the process stayed under control; the sterility test is the final step before release – for a clinical trial batch as much as for a commercial lot.

    → Read more about sterility testing

Technology

Understanding Grade A – technologies for aseptic processes

Hotspot image
  • Industrial pharmaceutical filling line with a large stainless steel isolator system, integrated glove ports, and overhead material delivery in a bright, modern cleanroom facility by SKAN.

    Isolator technology

    How an isolator ensures Grade A – and which design decisions need to be made early.

    Read more
  • Operators using flexible FlexFill modules.

    Isolator or RABS?

    How the two systems compare on requirements, operation and cost of ownership.

    Read more
  • H₂O₂ decontamination

    How H₂O₂ inactivates microorganisms and how the efficacy of a cycle is demonstrated.

    Read more
  • Filters

    How HEPA filters work and how their integrity is tested once installed.

    Read more
  • Close up of catalytic converter surface

    Catalysts

    How catalysts break down H₂O₂ after decontamination and shorten aeration times.

    Read more
  • case-story-merz
    Case Story

    Scaling production at speed

    How Merz Pharma, SKAN and partners rapidly implemented a high-performance filling line – tripling production capacity within a short timeframe through an integrated, scalable and efficient solution.

    Read more
  • Case_Story_Civica
    Case Story

    For reliable access to medicines in the US

    How Civica, SKAN and groninger are building a flexible manufacturing setup in the US – designed to reduce drug shortages and ensure a reliable, affordable supply of essential medicines for patients. 

    Read more
  • case-story-crb
    Case Story

    Project delivery and know-how from a single source

    How CRB and SKAN combine project execution and training – not only delivering facilities, but building capabilities and preparing teams for future requirements in aseptic manufacturing.

    Read more

Let’s talk about your process

Every aseptic process is different. Our experts take the time to answer your questions, from clinical development to ongoing operations.

Back to top